Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Whereas, the cost will fall between Rs 750 and Rs 1,300 for Sematrinity
Not Suitable for All Patients: Contraindicated in people with a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Semaglutide is a weight loss drug that targets the glucagon-like peptide-1 (GLP-1), sold by Novo Nordisk under the brand name Wegovy to treat people with obesity and under Ozempic to treat patients with both type 2 diabetes and obesity
any dosing figures describe clinical-trial or research settings, not a personal protocol
US$ 27.34
US$ 20.42
US$ 26.21
US$ 26.44
US$ 28.95
US$ 29.69
US$ 26.44
US$ 29.02
US$ 24.46
US$ 26.38
US$ 28.74
